Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:IBB NYSEARCA:IXJ NYSEARCA:IYH NYSEARCA:XBI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIBBiShares Biotechnology ETF$171.59+2.4%$169.70$123.61▼$179.64$8.06B0.721.67 million shs712,499 shsIXJiShares Global Healthcare ETF$95.06+3.0%$93.36$82.16▼$101.78$3.70B0.58269,810 shs59,844 shsIYHiShares U.S. Healthcare ETF$63.93+2.8%$61.65$53.94▼$67.63$2.99B0.59789,591 shs362,356 shsXBISPDR S&P Biotech ETF$133.59+2.9%$131.53$80.90▼$139.19$8.52B0.859.21 million shs4.46 million shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIBBiShares Biotechnology ETF-1.10%-1.40%+0.14%-0.69%+34.18%IXJiShares Global Healthcare ETF+0.39%-1.99%-0.14%-4.94%+7.69%IYHiShares U.S. Healthcare ETF+0.96%-0.67%+1.82%-3.28%+11.59%XBISPDR S&P Biotech ETF+1.62%-3.44%-0.45%+4.79%+57.68%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIBBiShares Biotechnology ETF$171.59+2.4%$169.70$123.61▼$179.64$8.06B0.721.67 million shs712,499 shsIXJiShares Global Healthcare ETF$95.06+3.0%$93.36$82.16▼$101.78$3.70B0.58269,810 shs59,844 shsIYHiShares U.S. Healthcare ETF$63.93+2.8%$61.65$53.94▼$67.63$2.99B0.59789,591 shs362,356 shsXBISPDR S&P Biotech ETF$133.59+2.9%$131.53$80.90▼$139.19$8.52B0.859.21 million shs4.46 million shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIBBiShares Biotechnology ETF-1.10%-1.40%+0.14%-0.69%+34.18%IXJiShares Global Healthcare ETF+0.39%-1.99%-0.14%-4.94%+7.69%IYHiShares U.S. Healthcare ETF+0.96%-0.67%+1.82%-3.28%+11.59%XBISPDR S&P Biotech ETF+1.62%-3.44%-0.45%+4.79%+57.68%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIBBiShares Biotechnology ETF 2.74Moderate Buy$171.820.13% UpsideIXJiShares Global Healthcare ETF 2.76Moderate Buy$95.06N/AIYHiShares U.S. Healthcare ETF 2.75Moderate Buy$63.93N/AXBISPDR S&P Biotech ETF 2.76Moderate Buy$133.620.02% UpsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/AIXJiShares Global Healthcare ETFN/AN/AN/AN/AN/AN/AIYHiShares U.S. Healthcare ETFN/AN/AN/AN/AN/AN/AXBISPDR S&P Biotech ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/AN/AN/AN/AIXJiShares Global Healthcare ETFN/AN/A21.58N/AN/AN/AN/AN/AN/AIYHiShares U.S. Healthcare ETFN/AN/A21.05N/AN/AN/AN/AN/AN/AXBISPDR S&P Biotech ETFN/AN/A11.47N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthIBBiShares Biotechnology ETF$0.390.23%N/AN/AN/AIXJiShares Global Healthcare ETF$1.361.43%N/AN/AN/AIYHiShares U.S. Healthcare ETF$0.801.25%N/AN/AN/AXBISPDR S&P Biotech ETF$0.440.33%N/AN/AN/ALatest XBI, IBB, IXJ, and IYH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/16/2026IBBiShares Biotechnology ETFQuarterly$0.12180.29%3/17/20263/17/20263/20/2026(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIBBiShares Biotechnology ETF62.45%IXJiShares Global Healthcare ETFN/AIYHiShares U.S. Healthcare ETFN/AXBISPDR S&P Biotech ETFN/AInsider OwnershipCompanyInsider OwnershipIBBiShares Biotechnology ETFN/AIXJiShares Global Healthcare ETFN/AIYHiShares U.S. Healthcare ETFN/AXBISPDR S&P Biotech ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIBBiShares Biotechnology ETFN/A47.00 millionN/AOptionableIXJiShares Global Healthcare ETFN/A38.90 millionN/ANot OptionableIYHiShares U.S. Healthcare ETFN/A46.75 millionN/ANot OptionableXBISPDR S&P Biotech ETFN/A63.80 millionN/ANot OptionableXBI, IBB, IXJ, and IYH HeadlinesRecent News About These Companies‘Buying stuff like it's going out of fashion': Biotech M&A on track for best year since pre-CovidJune 4 at 2:03 AM | cnbc.comHealthcare ETF Face-off: VHT, IXJ and XBI – Which Fits Your Portfolio?June 1 at 12:02 AM | nai500.comNVHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and CostMay 28, 2026 | finance.yahoo.comIs State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?May 27, 2026 | zacks.comBiotech Investors Are Tuning Out the MAHA ChaosMay 20, 2026 | wsj.comTrade Tracker: Joe Terranova sells the biotech ETF XBIMay 19, 2026 | msn.comIf You Hold This Healthcare ETF, You're Losing BigMay 19, 2026 | 247wallst.com2 Ways to Play the Big Pharma Patent Cliff...May 14, 2026 | marketbeat.comSPDR S&P Biotech ETF (XBI) Price Forecast: Long-Term Breakout Fuels Biotech StrengthMay 8, 2026 | fxempire.comFWhy this biotech ETF — the IBD stock of the day — just reentered its buy zoneMay 4, 2026 | msn.comLocking in a quick gain in this biotech ETF made room for better swing trades; here's whyMay 1, 2026 | msn.comShould You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?April 30, 2026 | zacks.comIs iShares Biotechnology ETF (IBB) a Strong ETF Right Now?April 28, 2026 | zacks.comEqual-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position NowApril 23, 2026 | 247wallst.comShould You Invest in the State Street SPDR S&P Biotech ETF (XBI)?April 22, 2026 | zacks.comXBI vs. IBB: The Biotech ETF Showdown That Analysts Say Has a Clear Winner in 2026April 7, 2026 | 247wallst.comThis Biotech ETF Is Still Well Below Its 2021 Peak. Analysts Say That Is Exactly Why to Buy It.April 3, 2026 | 247wallst.comBiotech Stocks Are Up About 35% in the Past Year and Analysts Say the Biggest Gains Are Still AheadMarch 28, 2026 | 247wallst.comIs State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?March 25, 2026 | zacks.comThe Zacks Analyst Blog Highlights IBB, XBI, BBH and GNOMMarch 17, 2026 | sharewise.comSBeyond Tech Industry: Here's how Biotech ETFs Are Riding the AI WaveMarch 16, 2026 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 2026Apple Talks Just Changed Everything for IntelBy Sam Quirke | May 6, 2026IonQ Just Posted a Breakout Quarter—But 1 Problem RemainsBy Nathan Reiff | May 7, 2026Before the Moon Base Gets Built, These 4 Companies WinBy Thomas Hughes | May 11, 20262 Ways to Play the Big Pharma Patent CliffBy Nathan Reiff | May 15, 2026XBI, IBB, IXJ, and IYH Company DescriptionsiShares Biotechnology ETF NASDAQ:IBB$171.59 +4.09 (+2.44%) As of 12:45 PM EasterniShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.iShares Global Healthcare ETF NYSEARCA:IXJ$95.06 +2.78 (+3.01%) As of 12:46 PM EasterniShares Global Healthcare ETF (the Fund), formerly iShares S&P Global Healthcare Sector Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Global 1200 Healthcare Sector Index (the Index). The Index measures the performance of companies that Standards & Poor's Financial Services LLC (S&P) deems to be a part of the consumer staples sector of the economy. It is a subset of the S&P Global 1200 Index. Component companies include healthcare providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals. The Underlying Index consists of stocks of companies in countries, including Australia, Belgium, Canada, Denmark, France, Germany, Ireland, Japan, the Netherlands, Switzerland, the United Kingdom and the United States. The Fund's investment advisor is BlackRock Fund Advisors (BFA).iShares U.S. Healthcare ETF NYSEARCA:IYH$63.93 +1.75 (+2.81%) As of 12:46 PM EasterniShares U.S. Healthcare ETF (the Fund), formerly iShares Dow Jones U.S. Healthcare Sector Index Fund (the Fund) is a non-diversified exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Dow Jones U.S. Health Care Index (the Index). The Index measures the performance of the healthcare sector of the United States equity market, and includes companies in the industry groups, such as healthcare equipment and services, pharmaceuticals and biotechnology. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund's investment advisor is BlackRock Fund Advisors (BFA).SPDR S&P Biotech ETF NYSEARCA:XBI$133.59 +3.76 (+2.90%) As of 12:46 PM EasternSPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas From Runway to Riches: Victoria's Secret's New Look Coke's $10B India IPO Plan Pops the Top on Hidden Value Dell's AI Toll Bridge Is Paved with Record Margins The Blue Origin Explosion Is a Setback for Amazon, Not a Dealbreaker Ulta's Q1 Report Primes It for a Beauty of a Rebound Palo Alto Networks Accelerates Growth 31% on AI Demand How the Memory Shortage Is Crushing the Gaming Industry As AI Data Breaches Become More Common, This Cybersecurity ETF Is Surging Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
